Condition: Kidney Transplant; Complications · Sponsor: University Medical Center Groningen
The REWARM study is a randomized controlled clinical efficacy study, with primary outcome renal function 12 months after transplantation of kidneys recovered from deceased donors aged 50 years or older. Prior to transplantation, kidney grafts in the intervention group will receive 6 hours of NMP, following standard HMP and kidneys in the control group will only receive standard treatment, being HMP. It is a multi-center trial. Given the total annual 50+ deceased donor kidney transplantation volume of the three participating transplant centers combined, inclusions in the study are expected to last 2.5-3 years, aiming for a total of 120 patients in each of the two arms (240 patients total).
This description comes directly from the study's public registry record.
Cyril Moers, MD, PhD · 0619602619 · c.moers@umcg.nl
Kirsten Ma, PhD · 0625651635 · k.f.ma@umcg.nl
Always discuss trial participation with your own doctor first.
| University Medical Center Groningen | Groningen, Provincie Groningen, Netherlands | Recruiting |
| Leiden University Medical Center | Leiden, Netherlands | Not Yet Recruiting |
| Erasmus Medical Center | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05782543